Stockreport

NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results

Nanobiotix S.A. - ADSs  (NBTX) 
PDF Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in oncology through lead programs [Read more]